Cargando…
Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics
BACKGROUND: The atypical antipsychotic clozapine is effective in treatment-resistant schizophrenia; however, the success or failure of clozapine therapy is substantially affected by the variables that impact the clozapine blood concentration. Thus, elucidating the inter-individual differences in clo...
Autores principales: | Tóth, Katalin, Csukly, Gábor, Sirok, Dávid, Belic, Ales, Kiss, Ádám, Háfra, Edit, Déri, Máté, Menus, Ádám, Bitter, István, Monostory, Katalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492788/ https://www.ncbi.nlm.nih.gov/pubmed/28340122 http://dx.doi.org/10.1093/ijnp/pyx019 |
Ejemplares similares
-
Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype
por: Tóth, Katalin, et al.
Publicado: (2016) -
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
por: Menus, Ádám, et al.
Publicado: (2020) -
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients
por: Fekete, Ferenc, et al.
Publicado: (2023) -
Relevance of CYP2C9 Function in Valproate Therapy
por: Monostory, Katalin, et al.
Publicado: (2019) -
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021)